Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth

DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation

(2013) M Lanzino et al.   Cell Death & Disease

Leptin Mediates Tumor-Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells

(2012) I. Barone et al.   CANCER RESEARCH

Estrogens and PTP1B Function in a Novel Pathway to Regulate Aromatase Enzymatic Activity in Breast Cancer Cells

(2012) Ines Barone et al.   ENDOCRINOLOGY

Inhibition of leydig tumor growth by farnesoid X receptor activation: Thein vitroandin vivobasis for a novel therapeutic strategy

(2012) Stefania Catalano et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of bioactive constituents of Ziziphus jujube fruit extracts exerting antiproliferative and apoptotic effects in human breast cancer cells

(2012) Pierluigi Plastina et al.   JOURNAL OF ETHNOPHARMACOLOGY

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

(2011) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells

(2011) Adele Vivacqua et al.   BREAST CANCER RESEARCH AND TREATMENT

Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells

(2011) Ubaldo E. Martinez-Outschoorn et al.   CANCER BIOLOGY & THERAPY

Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation

(2011) Guowei Gu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Loss of Rho GDIα and Resistance to Tamoxifen via Effects on Estrogen Receptor α

(2011) Ines Barone et al.   JNCI-Journal of the National Cancer Institute

Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression

(2011) C Giordano et al.   ONCOGENE

Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically.

(2010) Liam Morgan et al.   CANCER BIOLOGY & THERAPY

Nuclear Alternate Estrogen Receptor GPR30 Mediates 17 -Estradiol-Induced Gene Expression and Migration in Breast Cancer-Associated Fibroblasts

(2010) A. Madeo et al.   CANCER RESEARCH

Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling

(2010) I. Barone et al.   CLINICAL CANCER RESEARCH

Phosphorylation of the mutant K303R estrogen receptor α at serine 305 affects aromatase inhibitor sensitivity

(2010) I Barone et al.   ONCOGENE

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells

(2009) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305

(2009) Cinzia Giordano et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of the K303R Estrogen Receptor-  Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway

(2009) I. Barone et al.   CANCER RESEARCH

Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation

(2009) Benjamin C. Lin et al.   CANCER RESEARCH

Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF

(2009) Deo Prakash Pandey et al.   EMBO JOURNAL

Farnesoid X Receptor, through the Binding with Steroidogenic Factor 1-responsive Element, Inhibits Aromatase Expression in Tumor Leydig Cells

(2009) Stefania Catalano et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mechanisms of estrogen signaling and gene expression via GPR30

(2009) Eric R. Prossnitz et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Rapid Estradiol/ERα Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells

(2009) Stefania Catalano et al.   MOLECULAR ENDOCRINOLOGY

G Protein-Coupled Receptor 30 Expression Is Up-Regulated by EGF and TGFα in Estrogen Receptor α-Positive Cancer Cells

(2009) Adele Vivacqua et al.   MOLECULAR ENDOCRINOLOGY

Yin-Yang Activities and Vicious Cycles in the Tumor Microenvironment

(2008) I. P. Witz   CANCER RESEARCH

Epidermal Growth Factor Induces G Protein-Coupled Receptor 30 Expression in Estrogen Receptor-Negative Breast Cancer Cells

(2008) Lidia Albanito et al.   ENDOCRINOLOGY

The Novel Estrogen Receptor, G Protein-Coupled Receptor 30, Mediates the Proliferative Effects Induced by 17β-Estradiol on Mouse Spermatogonial GC-1 Cell Line

(2008) Rosa Sirianni et al.   ENDOCRINOLOGY

Retracted: G-Protein–Coupled Receptor 30 and Estrogen Receptor-α Are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer Cells

(2008) Lidia Albanito et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

The ins and outs of GPR30: A transmembrane estrogen receptor

(2008) Eric R. Prossnitz et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY